Serum soluble Fas (CD95) and Fas ligand profiles in chronic kidney failure

Journal of Laboratory and Clinical Medicine

Volumn 136, Issue 4, 2000, Pages 320-327

  Perianayagam, Mary C ^a   Murray, Sandra L ^a   Balakrishnan, V S ^a   Guo, Daqing ^a   King, Andrew J ^a   Pereira, Brian J G ^a   Jaber, Bertrand L ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033813770     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1067/mlc.2000.109318     Document Type: Article

References (30)

1. Apoptosis and disease
2. Apoptosis in leukocytes
3. Mechanisms of apoptotic cell death
4. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily
5. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
6. APO-1-induced apoptosis of leukemia cells from patients with adult T-cell leukemia
7. Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: Implications for the regulation of apoptosis in neutrophils
8. The expression of genes modulating programmed cell death in normal human polymorphonuclear neutrophils
9. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule
10. Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing
11. Soluble Fas/APO-1 in tumor cells: A potential regulator of apoptosis?
12. Expression of the Fas ligand in cells of T cell lineage
13. Fas and Fas ligand expression on human peripheral blood leukocytes
14. The Fas system, a regulator of testicular germ cell apoptosis, is differentially up-regulated in Sertoli cell versus germ cell injury of the testis
15. Metalloproteinase-mediated release of human Fas ligand
16. Fas ligand in human serum
17. Conversion of membrane-bound Fas (CD95) ligand to its soluble form is associated with down-regulation of its proapoptotic activity and loss of liver toxicity
18. Identification of soluble APO-1 in supernatants of human B- and T-cell lines and increased serum levels in B- and T-cell leukemias
19. Prognostic significance of soluble Fas in the serum of patients with bladder cancer
20. Increased circulating soluble form of Fas in patients with dilated cardiomyopathy
21. Elevated circulating levels and cardiac secretion of soluble Fas ligand in patients with congestive heart failure
22. Relationship between susceptibility to apoptosis and Fas expression in peripheral blood T cells from uremic patients: A possible mechanism for lymphopenia in chronic renal failure
23. Apoptosis of monocytes cultured from long-term hemodialysis patients
24. Neutrophil apoptosis and dysfunction in uremia
25. Neutrophil apoptosis in chronic renal failure (CRF): Role of the Fas/Fas ligand (FasL) pathway
26. Apoptosis-inducing activity of uremic plasma during hemodialysis
27. Microbiological and endotoxin considerations in hemodialyzer reprocessing
28. Differential induction of apoptosis by Fas-Fas ligand interactions in human monocytes and macrophages
29. Highly sensitive ELISA for soluble Fas in serum: Increased soluble Fas in the elderly